Diagnosis of chronic obstructive pulmonary disease in lung cancer screening Computed Tomography scans: independent contribution of emphysema, air trapping and bronchial wall thickening
- PMID: 23711184
- PMCID: PMC3673831
- DOI: 10.1186/1465-9921-14-59
Diagnosis of chronic obstructive pulmonary disease in lung cancer screening Computed Tomography scans: independent contribution of emphysema, air trapping and bronchial wall thickening
Abstract
Background: Beyond lung cancer, screening CT contains additional information on other smoking related diseases (e.g. chronic obstructive pulmonary disease, COPD). Since pulmonary function testing is not regularly incorporated in lung cancer screening, imaging biomarkers for COPD are likely to provide important surrogate measures for disease evaluation. Therefore, this study aims to determine the independent diagnostic value of CT emphysema, CT air trapping and CT bronchial wall thickness for COPD in low-dose screening CT scans.
Methods: Prebronchodilator spirometry and volumetric inspiratory and expiratory chest CT were obtained on the same day in 1140 male lung cancer screening participants. Emphysema, air trapping and bronchial wall thickness were automatically quantified in the CT scans. Logistic regression analysis was performed to derivate a model to diagnose COPD. The model was internally validated using bootstrapping techniques.
Results: Each of the three CT biomarkers independently contributed diagnostic value for COPD, additional to age, body mass index, smoking history and smoking status. The diagnostic model that included all three CT biomarkers had a sensitivity and specificity of 73.2% and 88.%, respectively. The positive and negative predictive value were 80.2% and 84.2%, respectively. Of all participants, 82.8% was assigned the correct status. The C-statistic was 0.87, and the Net Reclassification Index compared to a model without any CT biomarkers was 44.4%. However, the added value of the expiratory CT data was limited, with an increase in Net Reclassification Index of 4.5% compared to a model with only inspiratory CT data.
Conclusion: Quantitatively assessed CT emphysema, air trapping and bronchial wall thickness each contain independent diagnostic information for COPD, and these imaging biomarkers might prove useful in the absence of lung function testing and may influence lung cancer screening strategy. Inspiratory CT biomarkers alone may be sufficient to identify patients with COPD in lung cancer screening setting.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3673831/bin/1465-9921-14-59-1.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3673831/bin/1465-9921-14-59-2.gif)
Similar articles
-
The role of quantitative computed tomography in the diagnosis of chronic obstructive pulmonary disease.Pneumologia. 2016 Oct-Dec;65(4):184-8. Pneumologia. 2016. PMID: 29542899 Review.
-
Quantitative computed tomography measurements to evaluate airway disease in chronic obstructive pulmonary disease: Relationship to physiological measurements, clinical index and visual assessment of airway disease.Eur J Radiol. 2016 Nov;85(11):2144-2151. doi: 10.1016/j.ejrad.2016.09.010. Epub 2016 Sep 13. Eur J Radiol. 2016. PMID: 27776670 Free PMC article. Review.
-
Contribution of CT quantified emphysema, air trapping and airway wall thickness on pulmonary function in male smokers with and without COPD.COPD. 2014 Sep;11(5):503-9. doi: 10.3109/15412555.2014.933952. Epub 2014 Aug 5. COPD. 2014. PMID: 25093696
-
Paired inspiratory-expiratory chest CT scans to assess for small airways disease in COPD.Respir Res. 2013 Apr 8;14(1):42. doi: 10.1186/1465-9921-14-42. Respir Res. 2013. PMID: 23566024 Free PMC article.
-
Identification of chronic obstructive pulmonary disease in lung cancer screening computed tomographic scans.JAMA. 2011 Oct 26;306(16):1775-81. doi: 10.1001/jama.2011.1531. JAMA. 2011. PMID: 22028353
Cited by
-
The relationship of fat and muscle measurements with emphysema and bronchial wall thickening in smokers.ERJ Open Res. 2024 Mar 4;10(2):00749-2023. doi: 10.1183/23120541.00749-2023. eCollection 2024 Mar. ERJ Open Res. 2024. PMID: 38444665 Free PMC article.
-
Evaluation of retrieval accuracy and visual similarity in content-based image retrieval of chest CT for obstructive lung disease.Sci Rep. 2024 Feb 26;14(1):4587. doi: 10.1038/s41598-024-54954-5. Sci Rep. 2024. PMID: 38403628 Free PMC article.
-
Impact of COPD pulmonary structural remodeling on the prognosis of patients with advanced lung squamous cell carcinoma.Heliyon. 2023 Nov 4;9(11):e22042. doi: 10.1016/j.heliyon.2023.e22042. eCollection 2023 Nov. Heliyon. 2023. PMID: 38027974 Free PMC article.
-
ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer.Eur J Cardiothorac Surg. 2023 Oct 4;64(4):ezad302. doi: 10.1093/ejcts/ezad302. Eur J Cardiothorac Surg. 2023. PMID: 37804174 Free PMC article. Review.
-
Nomograms Using CT Morphological Features and Clinical Characteristics to Identify COPD in Patients with Lung Cancer: A Multicenter Study.Int J Chron Obstruct Pulmon Dis. 2023 Jun 12;18:1169-1185. doi: 10.2147/COPD.S405429. eCollection 2023. Int J Chron Obstruct Pulmon Dis. 2023. PMID: 37332841 Free PMC article.
References
-
- American Lung Association. Providing Guidance for Lung Cancer Screening: The American Lung Association Interim Report on Lung Cancer Screening. 2012. Available from: [ http://www.lung.org/finding-cures/research-news/new-screening-guidelines...]. Accessed February 2013.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical